Global Virology Market Analysis & Trends - Industry Forecast to 2025 - Product Image

Global Virology Market Analysis & Trends - Industry Forecast to 2025

  • ID: 4296424
  • Report
  • Region: Global
  • 160 pages
  • Accuray Research LLP
1 of 4

FEATURED COMPANIES

  • Abbott Laboratories
  • Abivax
  • AstraZeneca AB
  • GlaxoSmithKline plc
  • Johnson & Johnson
  • Merck and Co. Inc.
  • MORE
The Global Virology Market is poised to grow at a CAGR of around xx% over the next decade to reach approximately $xx billion by 2025.

This industry report analyzes the market estimates and forecasts of all the given segments on global as well as regional levels presented in the research scope. The study provides historical market data for 2014, 2015 revenue estimations are presented for 2016 and forecasts from 2017 till 2025. The study focuses on market trends, leading players, supply chain trends, technological innovations, key developments, and future strategies. With comprehensive market assessment across the major geographies such as North America, Europe, Asia Pacific, Middle East, Latin America and Rest of the world the report is a valuable asset for the existing players, new entrants and the future investors.

The study presents detailed market analysis with inputs derived from industry professionals across the value chain. A special focus has been made on 23 countries such as U.S., Canada, Mexico, U.K., Germany, Spain, France, Italy, China, Brazil, Saudi Arabia, South Africa, etc. The market data is gathered from extensive primary interviews and secondary research. The market size is calculated based on the revenue generated through sales from all the given segments and sub segments in the research scope. The market sizing analysis includes both top-down and bottom-up approaches for data validation and accuracy measures.

This report provides data tables, includes charts and graphs for visual analysis.

Regional Analysis:
North America
- US
- Canada
- Mexico

Europe
- France
- Germany
- Italy
- Spain
- UK
- Rest of Europe

Asia Pacific
- China
- Japan
- India
- Australia
- New Zealand
- Rest of Asia Pacific

Middle East
- Saudi Arabia
- UAE
- Rest of Middle East

Latin America
- Argentina
- Brazil
- Rest of Latin America

Rest of the World
- Africa
- Caribbean

Report Highlights:
- The report provides a detailed analysis on current and future market trends to identify the investment opportunities
- Market forecasts till 2025, using estimated market values as the base numbers
- Key market trends across the business segments, Regions and Countries
- Key developments and strategies observed in the market
- Market Dynamics such as Drivers, Restraints, Opportunities and other trends
- In-depth company profiles of key players and upcoming prominent players
- Growth prospects among the emerging nations through 2025
- Market opportunities and recommendations for new investments
READ MORE
Note: Product cover images may vary from those shown
2 of 4

FEATURED COMPANIES

  • Abbott Laboratories
  • Abivax
  • AstraZeneca AB
  • GlaxoSmithKline plc
  • Johnson & Johnson
  • Merck and Co. Inc.
  • MORE
1 Market Outline
1.1 Research Methodology
1.1.1 Research Approach & Sources
1.2 Market Trends
1.3 Regulatory Factors
1.4 Application Analysis
1.5 End User Analysis
1.6 Strategic Benchmarking
1.7 Opportunity Analysis

2 Executive Summary

3 Market Overview
3.1 Current Trends
3.1.1 Huge Investments in R & D
3.1.2 Increasing Application of Viroloy in Various Therapies
3.1.3 Recent Technological Developments in Virology
3.1.4 Growth Opportunities/Investment Opportunities
3.2 Drivers
3.3 Constraints
3.4 Industry Attractiveness
3.4.1 Bargaining power of suppliers
3.4.2 Bargaining power of buyers
3.4.3 Threat of substitutes
3.4.4 Threat of new entrants
3.4.5 Competitive rivalry

4 Virology Market, By Diagnosing Test
4.1 Interferons
4.1.1 Interferons Market Forecast to 2024 (US$ MN)
4.1.1.1 Cytokines
4.1.1.1.1 Cytokines Market Forecast to 2024 (US$ MN)
4.2 Viral Infection Controlling Methods
4.2.1 Viral Infection Controlling Methods Market Forecast to 2024 (US$ MN)
4.2.1.1 Passive Prophylaxis
4.2.1.1.1 Passive Prophylaxis Market Forecast to 2024 (US$ MN)
4.2.1.2 Immunoprophylaxis
4.2.1.2.1 Immunoprophylaxis Market Forecast to 2024 (US$ MN)
4.2.1.3 Active Prophylaxis (Vaccines)
4.3.1.3.1 Active Prophylaxis (Vaccines) Market Forecast to 2024 (US$ MN)
4.3 Antiviral Chemotherapy
4.3.1 Antiviral Chemotherapy Market Forecast to 2024 (US$ MN)
4.3.1.1 Antiviral Agents
4.3.1.1.1 Antiviral Agents Market Forecast to 2024 (US$ MN)
4.3.1.2 Immunomodulators
4.3.1.2.1 Immunomodulators Market Forecast to 2024 (US$ MN)
4.3.1.3 Virucidal Agents
4.3.1.3.1 Virucidal Agents Market Forecast to 2024 (US$ MN)
4.4 Diagnosing Test
4.4.1 Diagnosing Test Market Forecast to 2024 (US$ MN)
4.4.1.1 Deoxyribonucleic Acid (DNA) Viruses
4.4.1.1.1 Deoxyribonucleic Acid (DNA) Viruses Market Forecast to 2024 (US$ MN)
4.4.1.2 Ribonucleic Acid (RNA) Viruses
4.4.1.2.1 Ribonucleic Acid (RNA) Viruses Market Forecast to 2024 (US$ MN)
4.4.1.3 Prions Diagnostic Test
4.4.1.3.1 Prions Diagnostic Test Market Forecast to 2024 (US$ MN)
4.4.1.4 Other Viral Tests
4.4.1.4.1 Other Viral Tests Market Forecast to 2024 (US$ MN)

5 Virology Market, By End-User
5.1 Clinics
5.1.1 Clinics Market Forecast to 2025 (US$ MN)
5.2 Diagnostic Centres
5.2.1 Diagnostic Centres Market Forecast to 2025 (US$ MN)
5.3 Pharmacies
5.3.1 Pharmacies Market Forecast to 2025 (US$ MN)
5.4 Hospitals
5.4.1 Hospitals Market Forecast to 2025 (US$ MN)
5.5 Blood Banks
5.5.1 Blood Banks Market Forecast to 2025 (US$ MN)
5.5 Laboratories
5.5.1 Laboratories Market Forecast to 2025 (US$ MN)

6 Virology Market, By Application
6.1 Respiratory Tract Infections
6.1.1 Respiratory Tract Infections Market Forecast to 2025 (US$ MN)
6.2 Urinary Tract Infections
6.2.1 Urinary Tract Infections Market Forecast to 2025 (US$ MN)
6.3 CNS Infections
6.3.1 CNS Infections Market Forecast to 2025 (US$ MN)
6.4 Perinatal Infections
6.4.1 Perinatal Infections Market Forecast to 2025 (US$ MN)
6.5 Sexually Transmitted Diseases
6.5.1 Sexually Transmitted Diseases Market Forecast to 2025 (US$ MN)
6.6 Skin and Soft Tissue Infections
6.6.1 Skin and Soft Tissue Infections Market Forecast to 2025 (US$ MN)
6.7 GI Tract Infections
6.7.1 GI Tract Infections Market Forecast to 2025 (US$ MN)
6.8 Eye Infections
6.8.1 Eye Infections Market Forecast to 2025 (US$ MN)

7 Virology Market, By Geography
7.1 North America
7.1.1 North America Market Forecast by Countries to 2025 (US$ MN)
7.1.1.1 US
7.1.1.2 Canada
7.1.1.3 Mexico
7.2 Europe
7.2.1 Europe Market Forecast by Countries to 2025 (US$ MN)
7.2.1.1 France
7.2.1.2 Germany
7.2.1.3 Italy
7.2.1.4 Spain
7.2.1.5 UK
7.2.1.6 Rest of Europe
7.3 Asia Pacific
7.3.1 Asia Pacific Market Forecast by Countries to 2025 (US$ MN)
7.3.1.1 China
7.3.1.2 Japan
7.3.1.3 India
7.3.1.4 Australia
7.3.1.5 New Zealand
7.3.1.6 Rest of Asia Pacific
7.4 Middle East
7.4.1 Middle East Market Forecast by Countries to 2025 (US$ MN)
7.4.1.1 Saudi Arabia
7.4.1.2 UAE
7.4.1.3 Rest of Middle East
7.5 Latin America
7.5.1 Latin America Market Forecast by Countries to 2025 (US$ MN)
7.5.1.1 Argentina
7.5.1.2 Brazil
7.5.1.3 Rest of Latin America
7.6 Rest of the World (RoW)
7.6.1 RoW Market Forecast by Countries to 2025 (US$ MN)
7.6.1.1 Africa
7.6.1.2 Caribbean

8 Key Player Activities
8.1 Mergers & Acquisitions
8.2 Partnerships, Joint Venture’s, Collaborations and Agreements
8.3 Product Launch & Expansions
8.4 Other Activities

9 Leading Companies
9.1 Siemens
9.2 Roche
9.3 Novartis International AG
9.4 Merck and Co. Inc.
9.5 Johnson & Johnson
9.6 GlaxoSmithKline plc
9.7 Boehringer Ingelheim Corporation
9.8 AstraZeneca AB
9.9 Abivax
9.10 Abbott Laboratories

List of Tables
Table 1 Global Virology Market By Region, Market Forecast (2014-2025) (US$ MN)
Table 2 Global Virology Market By Diagnosing Test, Market Forecast (2014-2025) (US$ MN)
Table 3 Global Virology Market By Interferons, Market Forecast (2014-2025) (US$ MN)
Table 4 Global Virology Market By Cytokines, Market Forecast (2014-2025) (US$ MN)
Table 5 Global Virology Market By Viral Infection Controlling Methods, Market Forecast (2014-2025) (US$ MN)
Table 6 Global Virology Market By Passive Prophylaxis, Market Forecast (2014-2025) (US$ MN)
Table 7 Global Virology Market By Immunoprophylaxis, Market Forecast (2014-2025) (US$ MN)
Table 8 Global Virology Market By Active Prophylaxis (Vaccines), Market Forecast (2014-2025) (US$ MN)
Table 9 Global Virology Market By Antiviral Chemotherapy, Market Forecast (2014-2025) (US$ MN)
Table 10 Global Virology Market By Antiviral Agents, Market Forecast (2014-2025) (US$ MN)
Table 11 Global Virology Market By Immunomodulators, Market Forecast (2014-2025) (US$ MN)
Table 12 Global Virology Market By Virucidal Agents, Market Forecast (2014-2025) (US$ MN)
Table 13 Global Virology Market By Diagnosing Test, Market Forecast (2014-2025) (US$ MN)
Table 14 Global Virology Market By Deoxyribonucleic Acid (DNA) Viruses, Market Forecast (2014-2025) (US$ MN)
Table 15 Global Virology Market By Ribonucleic Acid (RNA) Viruses, Market Forecast (2014-2025) (US$ MN)
Table 16 Global Virology Market By Prions Diagnostic Test, Market Forecast (2014-2025) (US$ MN)
Table 17 Global Virology Market By Other Viral Tests, Market Forecast (2014-2025) (US$ MN)
Table 18 Global Virology Market By End-User, Market Forecast (2014-2025) (US$ MN)
Table 19 Global Virology Market By Clinics, Market Forecast (2014-2025) (US$ MN)
Table 20 Global Virology Market By Diagnostic Centres, Market Forecast (2014-2025) (US$ MN)
Table 21 Global Virology Market By Pharmacies, Market Forecast (2014-2025) (US$ MN)
Table 22 Global Virology Market By Hospitals, Market Forecast (2014-2025) (US$ MN)
Table 23 Global Virology Market By Blood Banks, Market Forecast (2014-2025) (US$ MN)
Table 24 Global Virology Market By Laboratories, Market Forecast (2014-2025) (US$ MN)
Table 25 Global Virology Market By Application, Market Forecast (2014-2025) (US$ MN)
Table 26 Global Virology Market By Respiratory Tract Infections, Market Forecast (2014-2025) (US$ MN)
Table 27 Global Virology Market By Urinary Tract Infections, Market Forecast (2014-2025) (US$ MN)
Table 28 Global Virology Market By CNS Infections, Market Forecast (2014-2025) (US$ MN)
Table 29 Global Virology Market By Perinatal Infections, Market Forecast (2014-2025) (US$ MN)
Table 30 Global Virology Market By Sexually Transmitted Diseases, Market Forecast (2014-2025) (US$ MN)
Table 31 Global Virology Market By Skin and Soft Tissue Infections, Market Forecast (2014-2025) (US$ MN)
Table 32 Global Virology Market By GI Tract Infections, Market Forecast (2014-2025) (US$ MN)
Table 33 Global Virology Market By Eye Infections, Market Forecast (2014-2025) (US$ MN)
Note: Product cover images may vary from those shown
3 of 4

Loading
LOADING...

4 of 4
  • Siemens
  • Roche
  • Novartis International AG
  • Merck and Co. Inc.
  • Johnson & Johnson
  • GlaxoSmithKline plc
  • Boehringer Ingelheim Corporation
  • AstraZeneca AB
  • Abivax
  • Abbott Laboratories
Note: Product cover images may vary from those shown
5 of 4
Note: Product cover images may vary from those shown
Adroll
adroll